JPRN-jRCT2032230435招募中3 期
A clinical trial of Orthokeratology lenses (development code: L001) for myopia and myopic astigmatism of spherical diopter power more than -4.00D up to -6.00D
Ikai Kenzo0 个研究点目标入组 90 人开始时间: 2023年11月5日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 8age old 至 ot applicable（—）
- 性别
- All
入选标准
- •(1) Age at the time of consent acquisition: 8 years or older
- •(2) Persons who understand the outline of the clinical trial and signed the consent form. In the case of minors, consent of both the subject and his/her guardian is required.
- •(3) Spherical diopter power of the subject eye is within the applicable range (-4.00D to -6.00D). However, -4.00D is not included. The applicable range of cylindrical degree is 0 to -1.50D (for against-the-rule astigmatism (70 to 110), the applicable range of cylindrical power is 0 to -0.75D). )
- •(4) Best-corrected visual acuity of the subject eye: 1.0 or better
- •(5) The corneal refractive power (weak principal meridian value) of the subject eye: 40.00D to 46.25D
- •(6) The tear volume of subject eye which measured by the Schirmer I method, in 5 minutes, the wet length of the test paper is 5 mm or more.
- •(7) The endothelial cell density of the cornea of the subject eye is 2,000 cells/mm2 or more.
- •(8) Persons who can have the scheduled medical examinations and follow the procedures without fail.
- •(9) Persons who can use the investigational device appropriately and to keep the necessary hygiene management for wearing the investigational device. In the case of minors, the guardian should be able to support the subject.
- •(10) Persons who have been wearing hard contact lenses should stop wearing for at least two weeks, and persons who have been wearing soft contact lenses should stop wearing for at least one week, before having the applicable examination. During the withdrawal period wearing eyeglasses is permitted.
排除标准
- •(1) Patients with acute or subacute inflammation of the anterior eye segment
- •(2) Patients with ocular infections
- •(3) Patients with uveitis
- •(4) Patients with reduced corneal sensitivity.
- •(5) Patients with corneal epithelial defects
- •(6) Patients with eyelid abnormalities. However, if the investigator judged that the abnormality is not significant, the patient is permitted to participate in the clinical trial.
- •(7) Patients with severe lacrimation decreased (dry eye) or lacrimal apparatus disease
- •(8) Patients who have had an allergic reaction to the eye surface or eye accessory, or have had an exacerbation of such reaction, due to wearing contact lenses or using care products for contact lenses.
- •(9) Patients with systemic diseases affecting the eye or systemic diseases aggravated by orthokeratology lens wear.
- •(10) Patients with immune disorders (e.g., acquired immune deficiency syndrome, autoimmune disease) or diabetes mellitus
- •(11) Patients with eye diseases, injuries, or malformations that affect the cornea, conjunctiva, or eyelids
- •(12) Persons who have continuous or frequent hyperemia or foreign-body sensation in the eyes.
- •(13) Patients with edema, staining, opacity, or neovascularization when the cornea is observed with a slit lamp. However, if the investigator judged that abnormality is not significant, the patient is permitted to participate in the clinical trial.
- •(14) Persons who have unstable corneal refractive power (curvature radius) measurement values or severe irregular astigmatism, or signs of keratoconus.
- •(15) Persons who have undergone laser corneal refractive surgery or intraocular lens insertion surgery
- •(16) Patients who are taking or planning to take drugs that may cause dry eye or affect vision (e.g., anti-inflammatory corticosteroids, mydriatics/cycloplegics for treatment purposes)
- •(17) Women who are pregnant, breastfeeding or planning to become pregnant during the study period
- •(18) Persons whose occupation always requires appropriate vision and have difficulty in taking a break from work when their vision is impaired
- •(19) Persons who are undergoing orthokeratology treatment in subject eye.
- •(20) Persons who are participating in other clinical trials. Those who participated in a contact lens clinical trial within 30 days before the applicable examination. Persons who participated in other clinical trials within 90 days before the applicable examination
- •(21) Others, persons who are considered inappropriate by the investigator.
研究者
相似试验
已完成
不适用
Clinical Trial of Orthokeratology Lens (MCOK-01)MyopiaNCT06037850Menicon Co., Ltd.390
进行中（未招募）
3 期
An evaluation test of Orthokeratology lenses(MCOK-01)Myopia or mild myopic astigmatismJPRN-jRCT2032220206Hiraoka Takahiro91
已完成
不适用
Study of surgical outcome on new extra ocular muscles and re-operation on the same Extra ocular muscle use in previous surgery in Residual and consecutive strabismusesotropia,exotropia.Exotropia (alternating)(monocular), except intermittent,vH50.0,H50.IRCT2017082135295N1Ahvaz University of Medical Sciences24
已完成
不适用
Myopia Control With Orthokeratology Contact Lenses in SpainMyopia, ProgressiveChildren, OnlyContact Lens ComplicationPerception, SelfAxial MyopiaNCT04806763Menicon Co., Ltd.69
尚未招募
不适用
Assess the Effects of Spectacles or Orthokeratology on Dry Eye Parameters in Children and Adolescents.Dry Eye DiseaseNCT06023108He Eye Hospital300